Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$114M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$31.3M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$26.4M |
| 4 |
Tyler Technologies
TYL
|
+$25M |
| 5 |
Brown & Brown
BRO
|
+$18.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$249M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Alibaba
BABA
|
+$140M |
| 5 |
Amazon
AMZN
|
+$99.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.7% |
| 2 | Healthcare | 14.91% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Communication Services | 10.34% |
| 5 | Industrials | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
La-Z-Boy
LZB
$1.67B
| $2.81M | ﹤0.01% |
89,200
+1,400
| +2% | +$46.9K |
|
1527
Resideo Technologies
REZI
$3.1B
| $2.81M | ﹤0.01% |
235,100
+4,800
| +2% | +$54.6K |
|
1528
Clearway Energy Class C
CWEN
$7.01B
| $2.8M | ﹤0.01% |
140,350
+2,600
| +2% | +$50.3K |
|
|
SYKE
1529
DELISTED
SYKES Enterprises Inc
SYKE
| $2.8M | ﹤0.01% |
75,623
| – | – |
|
|
ILPT
1530
Industrial Logistics Properties Trust
ILPT
$595M
| $2.79M | ﹤0.01% |
124,647
+2,500
| +2% | +$53.6K |
|
1531
Dave & Buster's
PLAY
$354M
| $2.79M | ﹤0.01% |
69,573
+1,100
| +2% | +$44K |
|
1532
Methode Electronics
MEI
$608M
| $2.79M | ﹤0.01% |
71,000
+1,500
| +2% | +$54.4K |
|
|
NVTA
1533
DELISTED
Invitae Corporation
NVTA
| $2.79M | ﹤0.01% |
173,100
+12,900
| +8% | +$228K |
|
|
ESPR
1534
DELISTED
Esperion Therapeutics
ESPR
| $2.79M | ﹤0.01% |
46,800
+1,500
| +3% | +$67.4K |
|
1535
US Physical Therapy
USPH
$1.21B
| $2.79M | ﹤0.01% |
24,400
+400
| +2% | +$49.8K |
|
|
SNBR
1536
DELISTED
Sleep Number
SNBR
| $2.76M | ﹤0.01% |
56,100
-700
| -1% | -$33.3K |
|
1537
Verra Mobility
VRRM
$717M
| $2.76M | ﹤0.01% |
197,400
+4,100
| +2% | +$58.8K |
|
|
ECOL
1538
DELISTED
US Ecology, Inc.
ECOL
| $2.76M | ﹤0.01% |
47,700
+6,200
| +15% | +$368K |
|
|
CTB
1539
DELISTED
Cooper Tire & Rubber Co.
CTB
| $2.76M | ﹤0.01% |
96,000
+1,900
| +2% | +$53.7K |
|
|
ALEX
1540
DELISTED
Alexander & Baldwin
ALEX
| $2.75M | ﹤0.01% |
131,420
+2,700
| +2% | +$61.1K |
|
1541
MaxLinear
MXL
$7.69B
| $2.75M | ﹤0.01% |
129,473
+3,700
| +3% | +$76.8K |
|
|
RARX
1542
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $2.75M | ﹤0.01% |
58,500
+7,000
| +14% | +$309K |
|
1543
First Commonwealth Financial
FCF
$2.18B
| $2.73M | ﹤0.01% |
188,500
+3,400
| +2% | +$47.7K |
|
1544
Universal Corp
UVV
$1.11B
| $2.73M | ﹤0.01% |
47,800
+900
| +2% | +$48.6K |
|
1545
Boise Cascade
BCC
$2.9B
| $2.73M | ﹤0.01% |
74,600
+1,600
| +2% | +$58.1K |
|
|
IRBT
1546
DELISTED
iRobot
IRBT
| $2.72M | ﹤0.01% |
53,800
+1,200
| +2% | +$60.2K |
|
|
BBT
1547
Beacon Financial Corp
BBT
$2.69B
| $2.72M | ﹤0.01% |
82,800
+800
| +1% | +$25.1K |
|
1548
TriMas Corp
TRS
$1.4B
| $2.72M | ﹤0.01% |
86,600
+1,400
| +2% | +$43.2K |
|
1549
Coca-Cola Consolidated
COKE
$12.6B
| $2.72M | ﹤0.01% |
95,650
+2,000
| +2% | +$56K |
|
|
RTL
1550
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $2.7M | ﹤0.01% |
203,360
+4,000
| +2% | +$57.2K |
|
Similar funds
Swiss National Bank's Q4 2019 Portfolio in Review
As of Q4 2019, Swiss National Bank held 2,602 positions worth $97.5B, up 3.6% from $94.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Swiss National Bank withdrew a net $3.98B in Q4 2019, closing 96 positions and reducing 725 holdings. Its most notable exit was Celgene Corp, an estimated $231M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Match Group worth $14.7M.
- Swiss National Bank's largest Q4 2019 buy was Match Group: 179,200 shares worth $14.7M.
- Swiss National Bank added most to Bristol-Myers Squibb in Q4 2019, an estimated $114M increase.
- Swiss National Bank's biggest Q4 2019 reduction was Apple, cutting an estimated $249M.
- Swiss National Bank fully exited Celgene Corp in Q4 2019, selling an estimated $231M.
- Swiss National Bank's ten largest holdings make up 19% of its $97.5B portfolio in Q4 2019.
- Swiss National Bank opened 82 new positions and closed 96 in Q4 2019.
- Swiss National Bank's portfolio value rose 3.6% quarter-over-quarter to $97.5B.
Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.